Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
about
Application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part I. Diagnosis of breast cancer prior to treatmentPositron Emission Tomography in Breast CancerRole of FDG PET-CT in evaluation of locoregional nodal disease for initial staging of breast cancer.Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years.Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET.Sentinel lymph node biopsy of the internal mammary chain in breast cancer.Clinical impact of (18)F-FDG PET/CT on initial staging and therapy planning for breast cancer.Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.2-(fluorine-18)-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography after breast conserving surgery: Correlation with molecular markers of breast cancerDetection of Internal Mammary Adenopathy in Patients With Breast Cancer by PET/CT and MRI.Special Relevance of FDG-PET as an Upfront Diagnostic Modality at Initial Diagnosis and in Suspected Recurrence in Patients of Breast Carcinoma Hailing From Lower Socioeconomic Status Owing to Relative Late Presentation: A Pilot Study in a Medical CClinical application of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer.Detection of internal mammary lymph node metastasis with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with stage III breast cancer.Present and future role of FDG-PET/CT imaging in the management of breast cancer.Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.Potential Clinical Applications of 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Mammography in Breast Cancer.Diagnostic implications of a small-voxel reconstruction for loco-regional lymph node characterization in breast cancer patients using FDG-PET/CT.Impact of pathologic diagnosis of internal mammary lymph node metastasis in clinical N2b and N3b breast cancer patients.Hybrid 18F-FDG PET/MRI might improve locoregional staging of breast cancer patients prior to neoadjuvant chemotherapy.Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.Comparisons of Positron Emission Tomography/Computed Tomography and Ultrasound Imaging for Detection of Internal Mammary Lymph Node Metastases in Patients With Breast Cancer and Pathologic Correlation by Ultrasound-Guided Biopsy Procedures.Internal mammary node adenopathy on breast MRI and PET/CT for initial staging in patients with operable breast cancer: prevalence and associated factors.(18)F-FDG PET as a single imaging modality in pediatric neuroblastoma: comparison with abdomen CT and bone scintigraphy.Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy.Role of 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Scan in Primary Staging of Breast Cancer Compared to Conventional Staging.
P2860
Q26751999-F2E6D61D-121D-48B6-9496-D5B3A5363EA9Q26768486-19BFEBAD-B1DC-4333-8496-84921638DEDDQ34657779-2417A0F6-16F4-4CE2-8A3A-E6E1110A8D4DQ35552138-FE83E5B7-4D1C-4221-8070-0B9A2D8D9CFFQ36104568-7A867114-D4AE-4794-AEEA-3E9DCFA7AE09Q36107120-8BB55744-C2C7-4644-A79F-99449C9144E7Q36409205-31FAC023-4A6E-47DA-95AF-2D48BF7AD476Q36476568-4E2285F4-542D-46CC-97A6-FD5718ED4249Q37032065-5E6764A1-1377-4D94-9332-6A63826F25D3Q37146074-0BF8CD6A-5AA6-4A30-B673-5157C4FCBD7FQ37660339-4777DB73-7D8A-4B5E-B85E-8F9C2E936366Q38165388-1EE8D5A3-9D89-4558-BB69-BEEFA24D59D5Q38445089-83DE0D9E-17AE-4353-A238-D4F386C9A7A5Q38687620-4DD7A76F-0A91-48E6-9D83-1EECD0D2A67DQ44456340-A14FBEA5-3E60-45E3-BD57-302715F1CC30Q47961966-F97DF67D-8049-4FBF-98B6-764925445F0DQ48230339-249BDFC2-F02F-4DE0-9084-63EE39AE79F8Q48276417-2D56E0DE-B478-4FED-9618-E5FCE24A6563Q48297177-7641E380-D93C-4D1D-9828-28462248352EQ48350058-927B3321-2569-4584-8A30-9A979839CCE6Q50877812-92CF8E2F-B603-4B8F-9DAD-98D89406F14BQ52974218-D30AB982-C074-4BBC-809D-E7065A755E08Q53081196-832FB7A7-7F60-49DE-9AC3-03BF0B3B2CB5Q53148285-41C27BB3-FBD1-4A9D-9B9D-F4EC381FB5CCQ55379188-A0210467-8862-44C1-A4B9-1BC7C5A292CD
P2860
Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Detection of extra-axillary ly ...... th stage II-III breast cancer.
@en
Detection of extra-axillary ly ...... th stage II-III breast cancer.
@nl
type
label
Detection of extra-axillary ly ...... th stage II-III breast cancer.
@en
Detection of extra-axillary ly ...... th stage II-III breast cancer.
@nl
prefLabel
Detection of extra-axillary ly ...... th stage II-III breast cancer.
@en
Detection of extra-axillary ly ...... th stage II-III breast cancer.
@nl
P2093
P1476
Detection of extra-axillary ly ...... th stage II-III breast cancer.
@en
P2093
Emiel J T Rutgers
Kenneth G A Gilhuijs
Marie-Jeanne T F D Vrancken Peeters
Marieke E Straver
Nicola S Russell
Renato A Valdés Olmos
Tjeerd S Aukema
Wouter V Vogel
P304
P356
10.1016/J.EJCA.2010.07.034
P577
2010-08-16T00:00:00Z